145 related articles for article (PubMed ID: 35445030)
1. SHIP1 Activator AQX-1125 Regulates Osteogenesis and Osteoclastogenesis Through PI3K/Akt and NF-κb Signaling.
Xie X; Hu L; Mi B; Panayi AC; Xue H; Hu Y; Liu G; Chen L; Yan C; Zha K; Lin Z; Zhou W; Gao F; Liu G
Front Cell Dev Biol; 2022; 10():826023. PubMed ID: 35445030
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.
Lemm EA; Valle-Argos B; Smith LD; Richter J; Gebreselassie Y; Carter MJ; Karolova J; Svaton M; Helman K; Weston-Bell NJ; Karydis L; Williamson CT; Lenz G; Pettigrew J; Harwig C; Stevenson FK; Cragg M; Forconi F; Steele AJ; Cross J; Mackenzie L; Klener P; Packham G
Clin Cancer Res; 2020 Apr; 26(7):1700-1711. PubMed ID: 31831562
[TBL] [Abstract][Full Text] [Related]
3. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
4. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.
Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Wu J; Ogden N; MacRury T; Szabo C
Br J Pharmacol; 2013 Mar; 168(6):1506-18. PubMed ID: 23121445
[TBL] [Abstract][Full Text] [Related]
5. Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation.
Guo W; Li H; Lou Y; Zhang Y; Wang J; Qian M; Wei H; Xiao J; Xu Y
J Orthop Translat; 2021 May; 28():148-158. PubMed ID: 33981577
[TBL] [Abstract][Full Text] [Related]
6. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo.
Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Chernoff D; MacRury T; Szabo C
Br J Pharmacol; 2013 Mar; 168(6):1519-29. PubMed ID: 23121409
[TBL] [Abstract][Full Text] [Related]
7. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
8. Rosavin suppresses osteoclastogenesis
Zhang W; Zhang W; Huo L; Chai Y; Liu Z; Ren Z; Yu C
Ann Transl Med; 2021 Mar; 9(5):383. PubMed ID: 33842604
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
10. Asiatic Acid Attenuates Osteoporotic Bone Loss in Ovariectomized Mice Through Inhibiting NF-kappaB/MAPK/ Protein Kinase B Signaling Pathway.
Dong M; Zeng J; Yang C; Qiu Y; Wang X
Front Pharmacol; 2022; 13():829741. PubMed ID: 35211021
[TBL] [Abstract][Full Text] [Related]
11. Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis.
Zhong Z; Qian Z; Zhang X; Chen F; Ni S; Kang Z; Zhang F; Li D; Yu B
Front Pharmacol; 2019; 10():1530. PubMed ID: 31998129
[TBL] [Abstract][Full Text] [Related]
12. SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27.
Zhou P; Kitaura H; Teitelbaum SL; Krystal G; Ross FP; Takeshita S
J Immunol; 2006 Dec; 177(12):8777-84. PubMed ID: 17142780
[TBL] [Abstract][Full Text] [Related]
13. DEC1 deficiency protects against bone loss induced by ovariectomy through inhibiting inflammation.
Lin L; Qiang Z; Chen K; Huo Y; Liu W; Yang J
J Biomed Res; 2024 May; ():1-16. PubMed ID: 38807374
[TBL] [Abstract][Full Text] [Related]
14. Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling.
Kim MH; Lim HJ; Bak SG; Park EJ; Jang HJ; Lee SW; Lee S; Lee KM; Cheong SH; Lee SJ; Rho MC
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33339187
[TBL] [Abstract][Full Text] [Related]
15. AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis.
Cross J; Stenton GR; Harwig C; Szabo C; Genovese T; Di Paola R; Esposito E; Cuzzocrea S; Mackenzie LF
Br J Pharmacol; 2017 Sep; 174(18):3045-3057. PubMed ID: 28658529
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling.
Tang Y; Lv XL; Bao YZ; Wang JR
Climacteric; 2021 Jun; 24(3):253-260. PubMed ID: 33084419
[TBL] [Abstract][Full Text] [Related]
17. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
[TBL] [Abstract][Full Text] [Related]
18. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J
Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786
[TBL] [Abstract][Full Text] [Related]
19. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
[TBL] [Abstract][Full Text] [Related]
20. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
